News archive
BNP Paribas Group: Results as at 30 June 2021
The Board of Directors of BNP Paribas met on 29 July 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the second quarter 2021.
BNP Paribas receives approvals and completes the acquisition of Exane
BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for
BNP Paribas Group: Results as at 31 March 2021
The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.
News archive
BNP Paribas Group: Results as at 30 June 2021
The Board of Directors of BNP Paribas met on 29 July 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the second quarter 2021.
BNP Paribas receives approvals and completes the acquisition of Exane
BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for
BNP Paribas Group: Results as at 31 March 2021
The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.
